Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
复制标题
竞争性内源性 RNA 网络的综合分析揭示了预测肝细胞癌复发的潜在生物标志物
DOI:
10.1186/s12885-021-08173-0
复制
发表时间:
2021-04-20
期刊:
影响因子:
3.8
通讯作者:
Wu Z
中科院分区:
文献类型:
--
作者:
Yan P;Huang Z;Mou T;Luo Y;Liu Y;Zhou B;Cao Z;Wu Z
Hepatocellular carcinoma (HCC) is one of the most common and deadly malignant tumors, with a high rate of recurrence worldwide. This study aimed to investigate the mechanism underlying the progression of HCC and to identify recurrence-related biomarkers. We first analyzed 132 HCC patients with paired tumor and adjacent normal tissue samples from the Gene Expression Omnibus (GEO) database to identify differentially expressed genes (DEGs). The expression profiles and clinical information of 372 HCC patients from The Cancer Genome Atlas (TCGA) database were next analyzed to further validate the DEGs, construct competing endogenous RNA (ceRNA) networks and discover the prognostic genes associated with recurrence. Finally, several recurrence-related genes were evaluated in two external cohorts, consisting of fifty-two and forty-nine HCC patients, respectively. With the comprehensive strategies of data mining, two potential interactive ceRNA networks were constructed based on the competitive relationships of the ceRNA hypothesis. The ‘upregulated’ ceRNA network consists of 6 upregulated lncRNAs, 3 downregulated miRNAs and 5 upregulated mRNAs, and the ‘downregulated’ network includes 4 downregulated lncRNAs, 12 upregulated miRNAs and 67 downregulated mRNAs. Survival analysis of the genes in the ceRNA networks demonstrated that 20 mRNAs were significantly associated with recurrence-free survival (RFS). Based on the prognostic mRNAs, a four-gene signature (ADH4, DNASE1L3, HGFAC and MELK) was established with the least absolute shrinkage and selection operator (LASSO) algorithm to predict the RFS of HCC patients, the performance of which was evaluated by receiver operating characteristic curves. The signature was also validated in two external cohort and displayed effective discrimination and prediction for the RFS of HCC patients. In conclusion, the present study elucidated the underlying mechanisms of tumorigenesis and progression, provided two visualized ceRNA networks and successfully identified several potential biomarkers for HCC recurrence prediction and targeted therapies. The online version contains supplementary material available at 10.1186/s12885-021-08173-0.
登录
查看更多内容
影响因子:
14.9
作者:
Ritchie ME;Phipson B;Wu D;Hu Y;Law CW;Shi W;Smyth GK
通讯作者:
Smyth GK
影响因子:
5.2
作者:
Han LL;Yin XR;Zhang SQ
通讯作者:
Zhang SQ
DOI:
10.1002/cjp2.37
发表时间:
2016-04
期刊:
The journal of pathology. Clinical research
影响因子:
--
作者:
Makowska Z;Boldanova T;Adametz D;Quagliata L;Vogt JE;Dill MT;Matter MS;Roth V;Terracciano L;Heim MH
通讯作者:
Heim MH
影响因子:
3.8
作者:
Liu X;Li T;Kong D;You H;Kong F;Tang R
通讯作者:
Tang R
影响因子:
4.1
作者:
Sun, Xiangjun;Ge, Xinfeng;Chen, Dongfeng
通讯作者:
Chen, Dongfeng